cp 10

CP-10 is a PROTAC with highly selective and remarkable CDK6 degradation (DC50: 2.1 nM). It inhibits the proliferation of several hematopoietic cancer cells including multiple myeloma and can degrade mutated and overexpressed CDK6.

Ethyl cellulose (viscosity 10 cP) 是无毒且可生物降解的聚合物，具有独特的油凝胶形成、活性成分输送和成膜能力，在食品和制药领域广泛应用。它可作为药用辅料，包括包衣剂、调味剂、片剂填充剂等。

Protein kinase inhibitor

CP 100356 is a specific inhibitor of MDR1 (P-Gp), the protypical ABC transporter. The compound has low uM to nM potency for inhibiting several MDR-1 substrates (calcein-AM, digoxin) in transfected MDCKII cells.

Fenclonine (CP-10188) 是一种有效的色氨酸羟化酶(Trp)的不可逆抑制剂。其中色氨酸羟化酶是 5-羟色胺生物合成的限速酶。

Pimavanserin (ACP-103) 是特异性的 5-HT2A 受体反向激动剂，在基于细胞的功能测定中，平均 pIC50值为8.7。它是非典型抗精神病药，用于治疗帕金森病患者的幻觉和精神病。

Pimavanserin tartrate 是一种有效的5-HT 2A 受体反向激动剂，用于治疗与帕金森病相关的精神病，对NFAT信号通路具有最有效的抑制活性。

Orbifloxacin (CP-104354) 是一种可用于犬类的氟喹诺酮类合成广谱抗生素。

ACP-105 是选择性的、可口服的雄激素受体调节剂 , 能够作用于野生型 AR (pEC50:9.0)和 T877A 突变型 AR (pEC50:9.3)。

CP-105696 是一种具有强效性和选择性白三烯 B4 (LTB4) 受体拮抗剂，可用于研究异体移植物排斥反应。

CP-100356 hydrochloride 是一种具有口服活性和低微摩尔的 MDR1 (P-gp) 和 BCRP 双重抑制剂，是核苷酸衍生的底物类似物，对 MDR1 介导的 Calcein-AM 转运 和 BCRP 介导的 Prazosin 转运有抑制作用。CP-100356 抑制 OATP1B1，可在黑暗中诱导气孔张开。

CP-100829 is a bio-active chemical.

Mirificin (BCP10902) 是一种葛根中的异黄酮。它能够抑制酪氨酸酶(Tyrosinase)，IC50=12.66 μM。

CP-10447 is an inhibitor apolipoprotein B (apoB) and triglyceride secretion in human hepatoma cells (HepG2) by inhibiting MTP activity and stimulating the early ER degradation of apoB. It is useful tool for further study of the mechanisms of apoB secretion and triglyceride-rich lipoprotein assembly.

MRT-92 is a potent and selective Smoothened (Smo) receptor inhibitor. MRT-92 displays subnanomolar antagonist activity against Smo in various Hh cell-based assays. MRT-92 inhibits rodent cerebellar granule cell proliferation induced by Hh pathway activation through pharmacologic (half maximal inhibitory concentration [IC50] = 0.4 nM) or genetic manipulation. Smo is the target of anticancer drugs that bind to a long and narrow cavity in the 7-transmembrane (7TM) domain.

UCD74A HCl is a cell impermeant homolog of UCD38B, inhibitor of uPA (urokinase plasminogen activator).

CP-101537 is a MMP inhibitor.

CP102, an iron chelator, effectively reduces total non-heme and ferritin-stored iron levels in the livers of mice when provided through drinking water at a concentration of 2 mg/ml.

Traxoprodil (CP101606) 是一种有效的和选择性的NMDA 拮抗剂，能够保护海马神经元，其 IC50=10 nM。

Pomalidomide-PEG1-C2-N3 is a compound that has been synthesized as a conjugate of an E3 ligase ligand-linker. This compound incorporates the cereblon ligand based on Pomalidomide and a 1-unit PEG linker, which are commonly used in PROTAC technology. Utilizing Pomalidomide-PEG1-C2-N3, it is possible to design a selective CDK6 PROTAC degrader known as CP-10. CP-10 effectively induces the degradation of CDK6, displaying a DC50 value of 2.1 nM[1].

Palbociclib-propargyl, a PROTAC ligand targeting the protein CDK6, connects to the CRBN ligand through a PEG linker to form PROTAC CP-10. CP-10 exhibits a potent DC50 value of 2.1 nM against CDK6[1].

CP-724714 (CP724714) 是一种高效、选择性口服活性的 ErbB2 (HER2)酪氨酸激酶抑制剂，IC50为 10 nM。它能抑制完整细胞中 ErbB2 受体的自磷酸化，具有抗肿瘤活性。它对 EGFR 激酶有明显的选择性，IC50值为6400 nM。

CP673451 是选择性的血小板源生长因子受体 (PDGFR) 抑制剂，能够抑制 PDGFRα (IC50:10 nM) 和 PDGFRβ (IC50:1 nM) 的活性。

CP91149 是GP (糖原磷酸化酶)的抑制剂，能够促进糖原的重新合成，但不会造成糖原的过度积累。它对2型糖尿病具有潜在的研究价值。